Boston Scientific topped fourth-quarter expectations, but guidance for 2022 was lighter than expected and BSX stock tumbled.
Via:: Sports Headlines
What are you Nutz about?
Boston Scientific topped fourth-quarter expectations, but guidance for 2022 was lighter than expected and BSX stock tumbled.
Via:: Sports Headlines
Copyright © 2022 · Nutzmedia